President & Immunovant CEO
Fri, Feb 13, 2026
Feb 13
200,000 shares @ $3.85
Increased holdings by +12.10%
91st largest trade (out of 285)
Cluster Buy
Trade made by an officer
Part of a cluster of 4 transactions by 3 insiders
10b5-1 scheduled trade
33% win rate · -6.0% median edge vs SPY (81 trades, 90-day)
Insider trade was 85% below market price
Price 64% above 200-day moving average